Motile sperm domain containing 1 is upregulated by the Wnt/β-catenin signaling pathway in colorectal cancer

Oncol Lett. 2022 Jun 27;24(2):282. doi: 10.3892/ol.2022.13402. eCollection 2022 Aug.

Abstract

Aberrant activation of the Wnt/β-catenin signaling pathway plays a crucial role in the development and progression of colorectal cancer. Previously, we identified a set of candidate genes that were regulated by this signaling pathway, and the present study focused on motile sperm domain containing 1 (MOSPD1). Immunohistochemical staining revealed that the expression of MOSPD1 was elevated in tumor cells from colorectal cancer tissues compared with in non-tumor cells. Using ChIP-seq data and the JASPAR database, the regulatory region(s) in the MOSPD1 gene as a target of the Wnt/β-catenin signaling pathway were searched, and a region containing three putative TCF-binding motifs in the 3'-flanking region was identified. Additional analyses using reporter assay and ChIP-quantitative PCR suggested that this region harbors enhancer activity through an interaction with transcription factor 7 like 2 (TCF7L2) and β-catenin. In addition, chromatin conformation capture assay revealed that the 3'-flanking region interacts with the MOSPD1 promoter. These data suggested that MOSPD1 was regulated by the β-catenin/TCF7L2 complex through the enhancer element located in the 3'-flanking region. These findings may be helpful for future studies regarding the precise regulatory mechanisms of MOSPD1.

Keywords: Wnt; colorectal cancer; motile sperm domain containing 1; transcription factor 7 like 2; β-catenin.

Grants and funding

This work was supported by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research [grant no. JP20K07563 (K.Y.)].